| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.13153 |
| P698 | PubMed publication ID | 25772599 |
| P2093 | author name string | P I Terasaki | |
| G B Klintmalm | |||
| J G O'Leary | |||
| H Kaneku | |||
| L W Jennings | |||
| N Banuelos | |||
| P433 | issue | 4 | |
| P304 | page(s) | 1003-1013 | |
| P577 | publication date | 2015-03-13 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation | |
| P478 | volume | 15 |
| Q33422561 | ABO-compatible liver allograft antibody-mediated rejection: an update |
| Q64092638 | Anti-donor immunoglobulin G subclass in liver transplantation |
| Q28076193 | Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation |
| Q40967497 | Chronic rejection: Differences and similarities in various solid organ transplants |
| Q26780271 | Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation |
| Q38839248 | Clinically relevant interpretation of solid phase assays for HLA antibody |
| Q46970385 | Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment |
| Q54969814 | Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. |
| Q50509418 | Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation. |
| Q64263915 | Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff |
| Q97518750 | Distribution of de novo Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and Severity |
| Q89910707 | Donor-Specific Antibodies in Liver Transplantation |
| Q46516137 | Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. |
| Q37590820 | From Humoral Theory to Performant Risk Stratification in Kidney Transplantation. |
| Q48112929 | Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. |
| Q52803938 | Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. |
| Q36010605 | Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant? |
| Q53187406 | Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays? |
| Q98784871 | Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies |
| Q91455802 | Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"? |
| Q37611251 | Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? |
| Q48135398 | Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection. |
| Q42174325 | The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. |
| Q91089875 | The Role of Complement in Liver Injury, Regeneration, and Transplantation |
| Q39121357 | The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives. |
| Q90194038 | The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage |
| Q93065771 | The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation |
| Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
| Q40634986 | Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss |
Search more.